MMJ PhytoTech Ltd (ASX:MMJ) Quarterly Update Report

Warning message

The subscription service is currently unavailable. Please try again later.

Perth, Nov 2, 2015 AEST (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) ("MMJ" or the "Company") today announces its activities report for the quarter ended 30 September 2015. 

Highlights:

- PhytoTech Medical and MMJ Bioscience merger successfully closed in late July, strategically positioning the Company as a vertically-integrated, Medical Cannabis ("MC") company with operations across the entire MC value chain and in key MC markets

- Trading in the combined MMJ PhytoTech Limited ("MMJ" or the "Company") on the ASX commenced 28 July 2015 after completion of oversubscribed $4.8m equity offering

- New Board members and management welcomed, Scientific Advisory Board dissolved

- Minor post-merger integration of business units completed smoothly with operations streamlined in to three business units spanning "Farm to Pharma": Cultivation, Pharmaceutical Processing and Clinical Development

- Cultivation: Duncan Facility completed and awaiting inspection by Health Canada after final security...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.